Diagnostics groups test EMEA pulse

摘要

Three medical diagnostics groups from Europe and the Middle East were at varying stages of initial public offerings last week, highlighting an increased appetite for healthcare stocks that has also witnessed an uptick in biotechnology groups opting for local rather than US listings. Management was in Paris last Wednesday for the launch of roadshows for a €440m-€474m Euronext IPO of French medical diagnostics group labco. The price range is €7-€9, which will fetch primary proceeds for the company of €320m, with between €120m and €154m of secondary selling.